Smith Beth Ann 4

4 · MACROGENICS INC · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 17, 2026

MacroGenics (MGNX) VP Beth Ann Smith Receives RSUs, Exercises Derivative

What Happened

Beth Ann Smith, VP, Controller & Treasurer of MacroGenics (MGNX), received two restricted stock unit (RSU) awards on 2026-02-12 totaling 109,375 RSUs (15,625 + 93,750).
On 2026-02-15 the filing shows conversion/exercise activity of 1,095 derivative units into common shares. To cover tax withholding, 423 shares were surrendered (code F) at a reported share value of $1.71, producing a withholding amount of about $723.
The Form 4 also lists a related derivative “disposed” entry for 1,095 shares at $0, which appears to reflect settlement mechanics of the conversion (reported as code M for exercise/conversion).

Key Details

Transaction dates: RSU grants on 2026-02-12; conversion/exercise and tax withholding on 2026-02-15. Filing date: 2026-02-17.
Grant amounts: 15,625 RSUs and 93,750 RSUs (total 109,375 RSUs) reported as awards (code A).
Conversion/exercise: 1,095 derivative units converted into shares (code M). Tax withholding: 423 shares withheld at $1.71/share for ~$723 (code F).
Shares owned after transaction: not specified in the filing.
Footnotes: prior RSU grant details and vesting schedules are included (e.g., a Feb 15, 2023 grant vesting in annual installments; RSUs convert one-for-one to common stock; staged vesting percentages noted).
Filing timeliness: Form filed 2026-02-17 covering Feb 12/15 activity; the filing does not indicate a late-report designation in the text of this summary.

Context

These transactions are largely awards and a conversion/settlement plus tax-withholding — typical reporting when RSUs vest or derivatives convert. The 423-share disposition was to satisfy tax obligations (not an open‑market sale for cash).
RSU grants are awards (not purchases) and do not by themselves signal a directional market bet; tax withholding and settlement entries are routine administrative steps following vesting or conversion.

Form 4

Period: 2026-02-12

VP, Controller & Treasurer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-15+1,095→ 13,204 total
Tax Payment
Common Stock
2026-02-15$1.71/sh−423$723→ 12,781 total
Exercise/Conversion
Restricted Stock Unit
[F1]
2026-02-15−1,095→ 0 total
→ Common Stock (1,095 underlying)
Award
Restricted Stock Unit
[F2]
2026-02-12+15,625→ 15,625 total
→ Common Stock (15,625 underlying)
Award
Employee Stock Option (right to buy)
[F3]
2026-02-12+93,750→ 93,750 total
Exercise: $1.71Exp: 2036-02-12→ Common Stock (93,750 underlying)

Footnotes (3)

[F1]On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
[F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
[F3]12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Signature

/s/ Beth Smith|2026-02-17

1 file